| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Yamasaki M et al. | Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro. | 2011 | J. Parasitol. | pmid:21756054 |
| Brito GN et al. | In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. | 2011 Jan-Feb | Braz Oral Res | pmid:21271179 |
| Xu L et al. | Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. | 2011 May-Jun | Mol Med Rep | pmid:21468584 |
| Kristanc L et al. | Effects of the pore-forming agent nystatin on giant phospholipid vesicles. | 2012 | Biochim. Biophys. Acta | pmid:22178865 |
| Kaufman DA | "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. | 2012 | Early Hum. Dev. | pmid:22633513 |
| Martins HP et al. | Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. | 2012 | Acta Derm. Venereol. | pmid:21918792 |
| Shanmughapriya S et al. | In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. | 2012 | Biofouling | pmid:22963125 |
| Blyth CC et al. | Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. | 2012 | J Paediatr Child Health | pmid:22970680 |
| Kaomongkolgit R et al. | Antifungal activity of coronarin D against Candida albicans. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22727093 |
| Fernández Campos F et al. | Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. | 2012 | J Pharm Sci | pmid:22777575 |
| Bzik VA et al. | Mechanisms of action of zinc on rat intestinal epithelial electrogenic ion secretion: insights into its antidiarrhoeal actions. | 2012 | J. Pharm. Pharmacol. | pmid:22471360 |
| Baugé C et al. | Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. | 2012 | Biochim. Biophys. Acta | pmid:22425785 |
| Semis R et al. | Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice. | 2012 | J. Antimicrob. Chemother. | pmid:22499997 |
| Bhattacharya S et al. | DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. | 2012 | Nano Lett. | pmid:22375622 |
| Tester R et al. | The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. | 2012 | Benef Microbes | pmid:22348910 |
| Jolivot PA et al. | [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. | 2012 | Pathol. Biol. | pmid:22361161 |
| Lee MJ et al. | Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. | 2012 | Appl. Microbiol. Biotechnol. | pmid:22382166 |
| Al-Dwairi ZN et al. | The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. | 2012 | J Prosthodont Res | pmid:22841909 |
| Kovac M et al. | Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. | 2012 | J Clin Pharm Ther | pmid:21332566 |
| Yang Y et al. | A chloroplast envelope membrane protein containing a putative LrgB domain related to the control of bacterial death and lysis is required for chloroplast development in Arabidopsis thaliana. | 2012 | New Phytol. | pmid:21916894 |